Ufp Technologies (UFPT) Return on Capital Employed (2011 - 2026)
Ufp Technologies (UFPT) posted Return on Capital Employed of 15.75% for Q1 2026, down 1.24% on a QoQ basis from 15.95% in Q4 2025, and down 10.0% year-over-year from 17.5% in Q1 2025.
Ufp Technologies (UFPT) Return on Capital Employed (2011 - 2026) Analysis & Trends
Ufp Technologies' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 15.75% for Q1 2026.
- Quarterly Return on Capital Employed fell 10.0% year-over-year to 15.75% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.75% (down 10.0% YoY) and the FY2025 annual result came in at 16.28%, down 209.0% from the prior year.
- Return on Capital Employed was 15.75% for Q1 2026 at Ufp Technologies, down from 15.95% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 19.54% in Q2 2023 and bottomed at 7.19% in Q1 2022.
- A 5-year average of 15.52% and a median of 16.3% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed soared 1143 bps — and 2024, when it tumbled 257 bps.
- Ufp Technologies' Return on Capital Employed stood at 16.93% in 2022, then fell by 1 bps to 16.77% in 2023, then dropped by 13 bps to 14.51% in 2024, then advanced by 10 bps to 15.95% in 2025, then slipped by 1 bps to 15.75% in 2026.
- Business Quant data shows UFPT's Return on Capital Employed at 15.75% in Q1 2026, 15.95% in Q4 2025, and 16.58% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ufp Technologies | 1.82 Bn | 1.80 Bn | 44.36 Mn | 15.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.75% |
| Dec 31, 2025 | 15.95% |
| Sep 30, 2025 | 16.58% |
| Jun 30, 2025 | 16.59% |
| Mar 31, 2025 | 15.85% |
| Dec 31, 2024 | 14.51% |
| Sep 30, 2024 | 15.79% |
| Jun 30, 2024 | 16.97% |
| Mar 31, 2024 | 17.19% |
| Dec 31, 2023 | 16.77% |
| Sep 30, 2023 | 16.30% |
| Jun 30, 2023 | 19.54% |
| Mar 31, 2023 | 18.62% |
| Dec 31, 2022 | 16.93% |
| Sep 30, 2022 | 14.71% |
| Jun 30, 2022 | 8.68% |
| Mar 31, 2022 | 7.19% |
| Dec 31, 2021 | 8.89% |
| Sep 30, 2021 | 10.75% |
| Jun 30, 2021 | 10.42% |